Hirohara J - Search Results

1

Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.

Yamashita Y, Umemura T, Kimura T, Joshita S, Hirohara J, Nakano T, Komori A, Tanaka A. Yamashita Y, et al. Among authors: hirohara j. JHEP Rep. 2022 Dec 24;5(4):100662. doi: 10.1016/j.jhepr.2022.100662. eCollection 2023 Apr. JHEP Rep. 2022. PMID: 36873419 Free PMC article.

2

Prediction of prognosis of primary biliary cirrhosis in Japan.

Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuchi K, Ohta Y, Onji M, Muto Y, Moriwaki H. Inoue K, et al. Among authors: hirohara j. Liver. 1995 Apr;15(2):70-7. doi: 10.1111/j.1600-0676.1995.tb00110.x. Liver. 1995. PMID: 7791541

3

[Primary biliary cirrhosis: epidemiological analysis].

Inoue K, Hirohara J, Nakano T. Inoue K, et al. Among authors: hirohara j. Nihon Naika Gakkai Zasshi. 1999 Apr 10;88(4):597-602. Nihon Naika Gakkai Zasshi. 1999. PMID: 10341643 Review. Japanese. No abstract available.

4

Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC).

Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M, Toda G. Nakano T, et al. Among authors: hirohara j. Hepatol Res. 2002 Apr;22(4):250-260. doi: 10.1016/s1386-6346(01)00148-6. Hepatol Res. 2002. PMID: 11929710

5

Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan.

Harada K, Hirohara J, Ueno Y, Nakano T, Kakuda Y, Tsubouchi H, Ichida T, Nakanuma Y. Harada K, et al. Among authors: hirohara j. Hepatology. 2013 May;57(5):1942-9. doi: 10.1002/hep.26176. Hepatology. 2013. PMID: 23197466 Free article.

6

[National surveys of primary biliary cirrhosis (PBC) in Japan].

Hirohara J, Nakano T, Seki T, Okazaki K, Nakanuma Y, Tsubouchi H. Hirohara J, et al. Nihon Shokakibyo Gakkai Zasshi. 2013 Jan;110(1):8-15. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 23303226 Japanese. No abstract available.

7

Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.

Tanaka A, Hirohara J, Nakanuma Y, Tsubouchi H, Takikawa H. Tanaka A, et al. Among authors: hirohara j. J Gastroenterol. 2015 Jun;50(6):675-82. doi: 10.1007/s00535-014-0998-z. Epub 2014 Sep 20. J Gastroenterol. 2015. PMID: 25239675

8

Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis.

Tanaka A, Hirohara J, Nakano T, Yagi M, Namisaki T, Yoshiji H, Nakanuma Y, Takikawa H; Japan PBC Study Group (JPBCSG). Tanaka A, et al. Among authors: hirohara j. Hepatol Res. 2018 Aug;48(9):727-734. doi: 10.1111/hepr.13068. Epub 2018 Mar 7. Hepatol Res. 2018. PMID: 29405510

9

Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis.

Tanaka A, Hirohara J, Nakano T, Matsumoto K, Chazouillères O, Takikawa H, Hansen BE, Carrat F, Corpechot C. Tanaka A, et al. Among authors: hirohara j. J Hepatol. 2021 Sep;75(3):565-571. doi: 10.1016/j.jhep.2021.04.010. Epub 2021 Apr 18. J Hepatol. 2021. PMID: 33882268

10

Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.

Nakamura N, Yoshida K, Tsuda R, Murata M, Yamaguchi T, Suwa K, Ichimura M, Tsuneyama K, Matsuzaki K, Nakano T, Hirohara J, Seki T, Okazaki K, Gershwin ME, Naganuma M. Nakamura N, et al. Among authors: hirohara j. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1480-1492. doi: 10.52586/5042. Front Biosci (Landmark Ed). 2021. PMID: 34994163 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page